CMS Pub. 100-04, ch. 32, § 411.1

Effective beginning on January 1, 2021, the Medicare home infusion therapy benefit covers the professional services,

including nursing services, furnished in accordance with the plan of care, patient training and education (not otherwise

covered under the durable medical equipment benefit), remote monitoring, and monitoring services for the provision of

home infusion therapy and home infusion drugs furnished by a qualified home infusion therapy supplier. Home infusion

therapy means the items and services furnished by a qualified home infusion therapy supplier, which are furnished in the

individual’s home. Payment is for an “infusion drug administration calendar day,” which means the day on which home

infusion therapy services are furnished by skilled professionals in the individual’s home on the day of infusion drug

administration. The skilled services provided on such day must be so inherently complex that they can only be safely and

effectively performed by, or under the supervision of, professional or technical personnel.